Page last updated: 2024-10-28

glyburide and Diabetic Angiopathies

glyburide has been researched along with Diabetic Angiopathies in 44 studies

Glyburide: An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide
glyburide : An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group.

Diabetic Angiopathies: VASCULAR DISEASES that are associated with DIABETES MELLITUS.

Research Excerpts

Excerpt	Relevance	Reference
"Glyburide was associated with a 52% greater risk of experiencing at least one episode of hypoglycemia compared with other secretagogues (relative risk 1."	8.84	A systematic review and meta-analysis of hypoglycemia and cardiovascular events: a comparison of glyburide with other secretagogues and with insulin. ( Clase, CM; Cukierman, T; Gangji, AS; Gerstein, HC; Goldsmith, CH, 2007)
"Glyburide was associated with a 52% greater risk of experiencing at least one episode of hypoglycemia compared with other secretagogues (relative risk 1."	4.84	A systematic review and meta-analysis of hypoglycemia and cardiovascular events: a comparison of glyburide with other secretagogues and with insulin. ( Clase, CM; Cukierman, T; Gangji, AS; Gerstein, HC; Goldsmith, CH, 2007)
"We conducted a population-based cohort study of patients aged 66 years and older who were hospitalized for acute myocardial infarction or who underwent percutaneous coronary intervention between 1 April 2007 and 31 March 2010 while receiving either glyburide or gliclazide."	3.78	Adverse cardiovascular events during treatment with glyburide (glibenclamide) or gliclazide in a high-risk population. ( Gomes, T; Juurlink, DN; Mamdani, MM; Shah, BR, 2012)
"Patients with Type 2 diabetes aged ≥ 21 years with 2-h postprandial glucose levels ≥ 11."	2.76	Nateglinide provides tighter glycaemic control than glyburide in patients with Type 2 diabetes with prevalent postprandial hyperglycaemia. ( Bellomo Damato, A; Giorgino, F; Giorgino, R; Laviola, L; Stefanelli, G, 2011)
"Troglitazone therapy was associated with increases in LDL size (26."	2.70	Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes. ( Armstrong, D; Baxi, S; Caulfield, M; Chu, NV; Deutsch, R; Henry, RR; Kim, DD; Kong, AP; Mudaliar, SR; Reaven, PD; Reitz, R, 2002)
"3867 newly diagnosed patients with type 2 diabetes, median age 54 years (IQR 48-60 years), who after 3 months' diet treatment had a mean of two fasting plasma glucose (FPG) concentrations of 6."	2.69	Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. ( , 1998)
"In patients with type 2 diabetes, intensive blood-glucose control with insulin or sulphonylurea therapy decreases progression of microvascular disease and may also reduce the risk of heart attacks."	2.69	Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. ( , 1998)
"Nateglinide was well tolerated with a low incidence of hypoglycemia in all subgroups, including those with RI and low baseline HbA(1c)."	2.42	Treatment of patients over 64 years of age with type 2 diabetes: experience from nateglinide pooled database retrospective analysis. ( Del Prato, S; Emmons, RP; Guitard, C; Heine, RJ; Keilson, L; Shen, SG, 2003)
"Treatment with glyburide significantly reduced aggregation in response to 10 microM of epinephrine and collagen at 750 microgram/ml."	2.36	Sulfonylureas and platelet function. ( Jackson, WP; Jacobs, P; Kernoff, L; Klaff, LJ; Vinik, AI, 1981)
"Glimepiride was associated with the best clinical outcome, showing the lowest mortality and lowest cardiovascular event risk of the five insulin secretagogues."	1.51	Comparison of mortality and cardiovascular event risk associated with various insulin secretagogues: A nationwide real-world analysis. ( Huang, HK; Yeh, JI, 2019)
"In older patients with type 2 diabetes hospitalized for IHD, prior use of gliclazide, glyburide, or repaglinide appears to be associated with a similar risk of adverse cardiovascular sequelae."	1.42	Comparative cardiovascular safety of insulin secretagogues following hospitalization for ischemic heart disease among type 2 diabetes patients: a cohort study. ( Abdelmoneim, AS; Huang, Y; Light, P; Qiu, W; Simpson, SH, 2015)
"Initiating treatment of type 2 diabetes with glibenclamide or glipizide is associated with increased risk of CAD in comparison to gliclazide or glimepiride."	1.35	Risk of coronary artery disease associated with initial sulphonylurea treatment of patients with type 2 diabetes: a matched case-control study. ( Mogensen, CE; Sadikot, SM, 2008)
"Treatment with glyburide and metformin significantly decreased plasma glucose concentrations from 207 (76) to 134 (52) mg/dl (p<0."	1.34	Improvement in coronary vascular dysfunction produced with euglycaemic control in patients with type 2 diabetes. ( Cadenas, J; Facta, AD; Hsueh, WA; Prior, JO; Quinones, MJ; Schelbert, HR; Schindler, TH, 2007)
"Type 2 diabetes mellitus is the consequence of both insulin resistance and impaired insulin secretion."	1.32	Optimal glycemic control in type 2 diabetes mellitus: fasting and postprandial glucose in context. ( Abrahamson, MJ, 2004)

Research

Studies (44)

Timeframe	Studies, this research(%)	All Research%
pre-1990	9 (20.45)	18.7374
1990's	8 (18.18)	18.2507
2000's	19 (43.18)	29.6817
2010's	8 (18.18)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Leonard, CE	1
Brensinger, CM	1
Aquilante, CL	1
Bilker, WB	1
Boudreau, DM	1
Deo, R	1
Flory, JH	1
Gagne, JJ	1
Mangaali, MJ	1
Hennessy, S	1
Huang, HK	1
Yeh, JI	1
Abdelmoneim, AS	2
Eurich, DT	1
Gamble, JM	1
Johnson, JA	1
Seubert, JM	1
Qiu, W	2
Simpson, SH	2
Huang, Y	1
Light, P	1
Wang, LP	1
Jiang, Y	1
Yang, H	1
Peng, C	1
Zhang, C	1
Tao, X	1
Xie, HH	1
Jojima, T	1
Suzuki, K	1
Hirama, N	1
Uchida, K	1
Hattori, Y	1
Sadikot, SM	1
Mogensen, CE	1
Nagayama, D	1
Saiki, A	1
Endo, K	1
Yamaguchi, T	1
Ban, N	1
Kawana, H	1
Ohira, M	1
Oyama, T	1
Miyashita, Y	1
Shirai, K	1
Bellomo Damato, A	1
Stefanelli, G	1
Laviola, L	1
Giorgino, R	1
Giorgino, F	1
Juurlink, DN	1
Gomes, T	1
Shah, BR	1
Mamdani, MM	1
Nieszner, E	1
Posa, I	1
Kocsis, E	1
Pogátsa, G	1
Préda, I	1
Koltai, MZ	1
Weintraub, NL	1
Del Prato, S	1
Heine, RJ	1
Keilson, L	1
Guitard, C	1
Shen, SG	1
Emmons, RP	1
Faglia, E	1
Abrahamson, MJ	1
Forlani, S	1
Tomai, F	1
De Paulis, R	1
Turani, F	1
Colella, DF	1
Nardi, P	1
De Notaris, S	1
Moscarelli, M	1
Magliano, G	1
Crea, F	1
Chiariello, L	1
Manzella, D	1
Grella, R	1
Abbatecola, AM	1
Paolisso, G	1
Schindler, TH	1
Facta, AD	1
Prior, JO	1
Cadenas, J	1
Hsueh, WA	1
Quinones, MJ	1
Schelbert, HR	1
Gangji, AS	1
Cukierman, T	1
Gerstein, HC	1
Goldsmith, CH	1
Clase, CM	1
Standl, E	1
Schnell, O	1
Blumenthal, SA	1
Velikov, VK	1
Shubina, IO	1
Saltykov, BB	1
Frolova, AI	1
Klaff, LJ	1
Kernoff, L	1
Vinik, AI	1
Jackson, WP	1
Jacobs, P	1
Jennings, PE	1
Feldman, S	1
Camus-Bablon, F	1
O'Brien, RC	1
Luo, M	1
Piccolo, I	1
Sterzi, R	1
Thiella, G	1
Klamann, A	1
Sarfert, P	1
Launhardt, V	1
Schulte, G	1
Schmiegel, WH	1
Nauck, MA	1
Gordon, EA	1
Guppy, LJ	1
Betteridge, DJ	1
Close, L	1
Kesavulu, MM	1
Rao, BK	1
Giri, R	1
Vijaya, J	1
Subramanyam, G	1
Apparao, C	1
Yamada, T	1
Komatsu, M	1
Sato, A	1
Komiya, I	1
Yamauchi, K	1
Aizawa, T	1
Hashizume, K	1
Brown, RA	1
Petrovski, P	1
Savage, AO	1
Ren, J	1
Reffelmann, T	1
Klues, HG	1
Hanrath, P	1
Schwarz, ER	1
Chu, NV	1
Kong, AP	1
Kim, DD	1
Armstrong, D	1
Baxi, S	1
Deutsch, R	1
Caulfield, M	1
Mudaliar, SR	1
Reitz, R	1
Henry, RR	1
Reaven, PD	1
Reddi, AS	1
Oppermann, W	1
Velasco, C	1
Camerini-Davalos, RA	1
Sauer, H	1
Schneider, B	1
Kawamori, R	1
Kamada, T	1
Mozaffari, MS	1
Allo, S	1
Schaffer, SW	1
Peacock, I	1
Hawkins, M	1
Heptinstall, S	1
Larkins, RG	1
Jerums, G	1
Taft, JL	1
Godfrey, H	1
Smith, IL	1
Martin, TJ	1
Malaisse, WJ	1
Leclercq-Meyer, V	1

Clinical Trials (54)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
Impact of Pantoprazole on 24-H Glycemic Control and on Post-prandial Glucose Excursion Inpatients With Type 2 Diabetes[NCT02345239]	Phase 3	14 participants (Anticipated)	Interventional	2015-02-28	Not yet recruiting
Glycemic Control Assessed by Continuous Glucose Monitoring in Hemodialyzed Patients With Diabetes Mellitus Treated Via the Basal-Bolus Detemir-Aspart Insulin Regimen: A Pilot Study[NCT01828970]	Phase 4	38 participants (Actual)	Interventional	2010-01-31	Completed
Effectiveness and Cost-effectiveness Analysis of a Telemonitoring Program on Lifestyle for People With Type 2 Diabetes at Home. Study Based on a Health Network in Diabetology.[NCT01955031]		282 participants (Actual)	Interventional	2013-11-30	Completed
The Study to Investigate the Contribution of Basal and Post-prandial Blood Glucose to Overall Glycaemia in Subjects With Normal Glycaemic Metabolism and Type 2 Diabetes[NCT02648685]		337 participants (Actual)	Observational	2015-11-30	Completed
Phase 1 Study To Determine the Effects of Short Term Near-infrared Light (NIR) Therapy on Anatomic and Functional Abnormalities of Diabetic Macular Edema, and Assess Safety of Short Term Near-infrared Light Therapy in Eyes With Diabetic Macular Edema.[NCT00846092]	Phase 1	4 participants (Actual)	Interventional	2007-11-30	Completed
Carbohydrate Days as Simple and Efficient Therapy for Patients With Type 2 Diabetes Mellitus and Insulin Resistance: Oatmeal and Insulin Resistance (OMA-IR).[NCT00401453]	Phase 3	15 participants (Anticipated)	Interventional	2007-01-31	Completed
Prospective, Parallel Goups Study, Aimed to Evaluating Possible Benefits of the Treatment of New Generation Hypoglycaemic Drugs Compared to Sulphonylureas for the Tratment of Type 2 Diabetes Mellitus[NCT04272359]		138 participants (Anticipated)	Observational [Patient Registry]	2019-05-06	Recruiting
Time in Glucose Hospital Target (TIGHT) - A Randomized Clinical Trial to Evaluate the Use of CGM to Achieve a Mean Glucose Target of 90 to 130 mg/dL Without Hypoglycemia in Hospitalized Adults With Type 2 Diabetes[NCT05135676]		150 participants (Anticipated)	Interventional	2022-05-10	Recruiting
A Multicentre Observational Study to Investigate the Improvement in Glucose FLuctuation of Sufficient Acarbose Therapy on Type 2 Diabetes Patient With High Blood Glucose Fluctuation[NCT03805191]		900 participants (Anticipated)	Observational	2019-01-01	Recruiting
The Effectiveness of Nurse Practitioner Led Group Visits in Improving Compliance With Diabetic Preventative Services and Modifying Vascular Risk[NCT00204282]		150 participants	Interventional	2003-08-31	Completed
Effects and Safety of GUideline Algorithm Based Intervention on CaRdiovascular and Renal Outcomes in Elderly Diabetic Patients With High Cardiovascular Risk in the Community- A Cluster Randomized Controlled Trial (GUARD-Community Study)[NCT05349955]		5,600 participants (Anticipated)	Interventional	2022-11-21	Recruiting
Comparative Effects of Empagliflozin Versus Glimepiride After 26-weeks of Treatment Add on Metformin on Myocardial Metabolic Rate of Glucose Estimated Through 18FDG-PET in Patients With Type 2 Diabetes[NCT04183868]	Phase 4	26 participants (Actual)	Interventional	2016-04-30	Completed
Randomized Trial to Assess the Effect of Using Alternate Site Blood Glucose Testing Versus Finger-Tip Testing on Long-Term Glycemic Control.[NCT00207207]	Phase 1	174 participants	Interventional	2003-07-31	Completed
GLUCOSE : Glucose Lowering by Usual Care Or Specialized Endocrinology Team[NCT00248352]		212 participants (Anticipated)	Interventional	2005-02-28	Completed
The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Gestational Diabetes Mellitus[NCT01795248]	Phase 4	105 participants (Actual)	Interventional	2012-07-31	Completed
"The Effect of Rehabilitation of Type 2 Diabetes Mellitus Versus Standard Outpatient Care. A Randomized Controlled Trial."[NCT00284609]		180 participants (Anticipated)	Interventional	2006-08-31	Completed
Effect of Different Doses of Salacinol Extract on Glycemic and Insulinemic Response in Patients With Type 2 Diabetes[NCT00306072]	Phase 1/Phase 2	82 participants	Interventional	2005-06-30	Completed
Effectiveness and Tolerability of Novel, Initial Triple Combination Therapy With Xigduo (Dapagliflozin Plus Metformin) and Saxagliptin vs. Conventional Stepwise add-on Therapy in Drug-naïve Patients With Type 2 Diabetes[NCT02946632]	Phase 3	104 participants (Anticipated)	Interventional	2016-12-31	Not yet recruiting
PRecisiOn MEdicine to Target Frailty of Endocrine-metabolic Origin[NCT04856683]		1,100 participants (Anticipated)	Observational	2020-08-10	Recruiting
A 16-wk, Uni-center, Randomized, Double-blind, Parallel, Phase 3b Trial to Evaluate Efficacy of Saxagliptin + Dapagliflozin vs.Dapagliflozin With Regard to EGP in T2DM With Insufficient Glycemic Control on Metformin+/-Sulfonylurea Therapy[NCT02613897]		56 participants (Actual)	Interventional	2016-01-31	Completed
Efficacy of a Virtual Care Clinic in the Management of Diabetes Mellitus[NCT02681185]		11 participants (Actual)	Interventional	2018-03-01	Terminated (stopped due to enrollment not satisfied)
Investigating if an Internet-Based Glucose Monitoring System is as Effective as Medication at Reducing HbA1c Levels in Type 2 Diabetes Mellitus[NCT02185755]		60 participants (Actual)	Interventional	2014-08-31	Completed
The Effect of a Checklist on the Quality of Education During Insulin Initiation by Trained Medical Students: a Randomized Controlled Trial[NCT02313805]		100 participants (Anticipated)	Interventional	2014-07-31	Recruiting
Intravitreal Injections of Ziv-aflibercept for Macular Diseases: Diabetic Macular Edema, Wet AMD and Macular Edema Secondary to Vein Occlusons[NCT02556723]		60 participants (Anticipated)	Interventional	2014-09-30	Completed
Differences in Hemoglobin Glycation Rate in Diabete Mellitus Patients[NCT01213277]		25 participants (Anticipated)	Interventional	2010-10-31	Suspended (stopped due to a pilot study of 7 patients did not reveal a temperature dependent difference in glycation rates)
HbA1c as an Early Serologic Marker for the Hemodynamic Progression of Stage A Heart[NCT04450576]		200 participants (Anticipated)	Observational	2019-12-20	Active, not recruiting
From Clinic to Community: Using Peer Support as a Transition Model for Improving Long-term Diabetes-related Health Outcomes[NCT02804620]	Early Phase 1	228 participants (Anticipated)	Interventional	2014-10-31	Recruiting
Research on Human Insulin rDNA (Insuget) Safety and Efficacy in Patients With Type 2 Diabetes Mellitus[NCT05161741]	Phase 4	238 participants (Actual)	Interventional	2021-01-01	Completed
Does Glycated Hemoglobin Variability in Type 2 Diabetes Differ Depending on the Diabetes Treatment Threshold Used in the Qatari Population: Implication on Diabetes Complication Risk?[NCT02879409]		150 participants (Anticipated)	Interventional	2016-11-30	Active, not recruiting
Effect of Internet Therapeutic Intervention on A1C Levels in Type 2 Diabetes Mellitus on Monotherapy[NCT01044368]		50 participants (Anticipated)	Interventional	2010-01-31	Suspended (stopped due to To focus on a similar study NCT01175408 prior to recruiting participants.)
STAMPEDE: Surgical Therapy And Medications Potentially Eradicate Diabetes Efficiently[NCT00432809]		150 participants (Actual)	Interventional	2007-02-28	Completed
Variability of Glucose Assessed in a Randomized Trial Comparing the Initiation of A Treatment Approach With Biosimilar Basal Insulin Analog Or a Titratable iGlarLixi combinatioN in Type 2 Diabetes Among South Asian Subjects (VARIATION 2 SA Trial)[NCT03819790]	Phase 4	119 participants (Actual)	Interventional	2018-10-02	Completed
A Multi-centre, Open-labeled, Randomized, Parallel Study on Liver Fat Content and Visceral Fat Mass in Overweight and Obese Type 2 Diabetes Patients After 26 Weeks Treatment With Insulin Detemir Once Daily Versus Insulin NPH Once Daily[NCT01310452]		50 participants (Anticipated)	Interventional	2011-01-31	Active, not recruiting
The Risk Factors of Cardiovascular Disease in Elderly Diabetic Patients: A Prospective Cohort Study[NCT04544527]		10,000 participants (Anticipated)	Observational	2020-09-01	Recruiting
Protocol: Comparing the Effect of Using an Internet-Based Glucose Monitoring System Versus the Continuous Glucose Monitoring System on HbA1c Levels in Type 2 DM[NCT01162694]		50 participants (Anticipated)	Interventional	2010-07-31	Suspended (stopped due to Study was expanded and included in another study.)
Effect of Internet Therapeutic Intervention on A1C Levels in Type 2 Diabetes Mellitus on Combination Oral Therapy[NCT01060241]		50 participants (Anticipated)	Interventional	2010-02-28	Suspended (stopped due to Other projects warranted more attention)
Blood Monitoring and Data Acquisition and Utilization in Patients With Type 2 Diabetes Treated With Insulin[NCT01175408]		100 participants (Actual)	Interventional	2010-09-30	Completed
Addition of Liraglutide to Overweight Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections (MDI) With Inadequate Glycaemic Control[NCT02113332]	Phase 2	124 participants (Actual)	Interventional	2013-01-31	Completed
SEMAGLUTIDE VERSUS GLP-1 RECEPTOR AGONISTS. EFFECTIVENESS , SAFETY AND QUALITY OF LIFE IN PATIENTS WITH DIABETES MELLITUS 2. OBSERVATIONAL, PROSPECTIVE AND MULTICENTER STUDY. SEVERAL STUDY.[NCT05136287]		140 participants (Actual)	Observational	2022-02-01	Active, not recruiting
A Prospective Consortium Evaluating the Long-term Follow-up of Patients With Type 2 Diabetes Enrolled In a Randomized Controlled Trial Comparing Bariatric Surgery Versus Medical Management[NCT02328599]		302 participants (Anticipated)	Observational	2018-04-10	Enrolling by invitation
Health Benefits of Aerobic and Resistance Training in Individuals With Type 2 Diabetes[NCT00458133]		262 participants (Actual)	Interventional	2007-04-30	Completed
Magnetic Resonance Assessment of Victoza Efficacy in the Regression of Cardiovascular Dysfunction In Type 2 Diabetes Mellitus[NCT01761318]	Phase 4	50 participants (Actual)	Interventional	2013-11-30	Completed
Financial Incentives and SMS to Improve African American Womens' Glycemic Control: Friends & Relatives Improving the Effectiveness of Networks for Diabetes Support Through Text Messaging (FRIENDS Text)[NCT02384265]		41 participants (Actual)	Interventional	2012-06-21	Completed
A Randomized, Multi-Center, Pivotal Efficacy and Safety Study Evaluating the EndoBarrier® System for Glycemic Improvement in Patients With Inadequately Controlled Type 2 Diabetes and Obesity[NCT04101669]		240 participants (Anticipated)	Interventional	2019-09-09	Recruiting
Effect of Metformin Glycinate on Postprandial Lipemia, Glycemic Control and Oxidation Markers in Type 2 Diabetes Patients[NCT02064881]	Phase 2/Phase 3	72 participants (Anticipated)	Interventional	2015-10-31	Recruiting
A Pilot Study to Evaluate Eli Lilly's Insulin Dosing Algorithm to Control Glycemia in Insulin-treated Adults With Type 2 Diabetes[NCT05514080]		10 participants (Actual)	Interventional	2019-12-06	Completed
The TELE-DD Project: a Nurse-led Randomised Controlled Trial on Treatment Adherence in Patients With Type 2 Diabetes and Comorbid Depression[NCT04097483]		428 participants (Actual)	Interventional	2017-01-31	Completed
A Randomized Phase 3 Trial of Metformin in Patients Initiating Androgen Deprivation Therapy as Prevention and Intervention of Metabolic Syndrome: The Prime Study[NCT03031821]	Phase 3	168 participants (Actual)	Interventional	2018-07-12	Terminated (stopped due to Manufacturer discontinued the production of study drugs.)
Metformin Pharmacology in Human Cancers[NCT03477162]	Early Phase 1	18 participants (Actual)	Interventional	2018-05-15	Terminated (stopped due to Enrollment was closed as efforts had become more challenging, and the lab indicated that they were able to obtain their primary objective with the number that had already been enrolled.)
The Effects of Metformin on Vascular Structure and Function in Subjects With the Metabolic Syndrome (MET Trial)[NCT00105066]	Phase 2	77 participants (Actual)	Interventional	2004-01-31	Completed
The Assessment of the Effect of Metformin and Its Serum Concentration on the Concentration of Substances Associated With the Production of Nitric Oxide in Patients With Impaired Carbohydrate Metabolism[NCT03398356]	Phase 4	47 participants (Actual)	Interventional	2017-10-20	Completed
Efficacy and Safety of Metformin Glycinate Compared to Metformin Hydrochloride on the Progression of Type 2 Diabetes[NCT04943692]	Phase 3	500 participants (Anticipated)	Interventional	2021-08-31	Suspended (stopped due to Administrative decision of the investigation direction)
Safety and Efficacy of Metformin Glycinate vs Metformin Hydrochloride on Metabolic Control and Inflammatory Mediators in Type 2 Diabetes Patients[NCT01386671]	Phase 3	203 participants (Actual)	Interventional	2014-06-30	Completed
Rosiglitazone And Fenofibrate Additive Effects on Lipids (RAFAEL)[NCT00819910]	Phase 4	41 participants (Actual)	Interventional	2008-09-30	Terminated (stopped due to Slow recruitment and increase in deployment overseas limiting follow up)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Change in BMI

Change in BMI (body mass index) from study start to 16 weeks (NCT02613897)
Timeframe: Change from baseline to 16 weeks

Intervention	Kg/m^2 (Mean)
DAPA/SAXA (Dapagliflozin Plus Saxagliptin)	-0.8
DAPA (Dapagliflozin Plus Placebo)	-0.66
PCB (Placebo Plus Placebo)	0.16

Change in Body Weight

Change in body weight from baseline to 16 weeks (NCT02613897)
Timeframe: Baseline to 16 weeks

Intervention	Kg (Mean)
DAPA/SAXA (Dapagliflozin Plus Saxagliptin)	-2.28
DAPA (Dapagliflozin Plus Placebo)	-1.76
PCB (Placebo Plus Placebo)	0.26

Change in Fasting Plasma Glucagon (FPG)

A measure of the change in fasting plasma glucagon from study start to 16 weeks (NCT02613897)
Timeframe: Change from baseline to 16 weeks

Intervention	mg/dl (Mean)
DAPA/SAXA (Dapagliflozin Plus Saxagliptin)	-28.52
DAPA (Dapagliflozin Plus Placebo)	26.89
PCB (Placebo Plus Placebo)	6.88

Change in Free Fatty Acids (FFA)

Measure of change in Free Fatty Acids from study start to 16 weeks (NCT02613897)
Timeframe: Change from baseline to 16 weeks

Intervention	mEq/L (Mean)
DAPA/SAXA (Dapagliflozin Plus Saxagliptin)	-0.06
DAPA (Dapagliflozin Plus Placebo)	-0.01
PCB (Placebo Plus Placebo)	0.00

Change in Glucose Oxidation

Change in percentage of glucose oxidation from study start to 16 weeks (NCT02613897)
Timeframe: Change from baseline to 16 weeks

Intervention	percentage of oxidation (Mean)
DAPA/SAXA (Dapagliflozin Plus Saxagliptin)	-22.07
DAPA (Dapagliflozin Plus Placebo)	-46.54
PCB (Placebo Plus Placebo)	4.65

Change in Lipid Oxidation

Change in lipid oxidation percentage from baseline to 16 weeks (NCT02613897)
Timeframe: Change from baseline to 16 weeks

Intervention	percentage of oxidation (Mean)
DAPA/SAXA (Dapagliflozin Plus Saxagliptin)	-11.87
DAPA (Dapagliflozin Plus Placebo)	22.02
PCB (Placebo Plus Placebo)	-6.69

HBA1c

Change in blood glucose level measured over a 3 month period from study start to 16 weeks (NCT02613897)
Timeframe: Change from baseline to 16 weeks

Intervention	percentage change in blood glucose level (Mean)
DAPA/SAXA (Dapagliflozin Plus Saxagliptin)	-1.67
DAPA (Dapagliflozin Plus Placebo)	-1.46
PCB (Placebo Plus Placebo)	0.44

Mean Oral Glucose Tolerance Test (OGTT)

Measure of change in OGTT from study start to 16 weeks (NCT02613897)
Timeframe: Change from baseline to 16 weeks

Intervention	mg/dl (Mean)
DAPA/SAXA (Dapagliflozin Plus Saxagliptin)	-49.62
DAPA (Dapagliflozin Plus Placebo)	-44.24
PCB (Placebo Plus Placebo)	20.26

Change in Endogenous Glucose Production (EGP)

All subjects received a Double-Tracer Oral Glucose Tolerance Test (OGTT) with 75g of glucose containing 14C-glucose together with intravenous primed-continuous infusion of 3(3H)-glucose for 240 minutes, at baseline (prior to) and after 16 weeks of therapy. Blood and urine samples were obtained during the OGTT to determine EGP. (NCT02613897)
Timeframe: Baseline and 16 weeks

Intervention	mg/kg*min (Mean)
	Baseline Measurement	16 weeks
DAPA (Dapagliflozin Plus Placebo)	2.56	2.8
DAPA/SAXA (Dapagliflozin Plus Saxagliptin)	2.45	2.4
PCB (Placebo Plus Placebo)	1.95	2.15

Body Mass Index (BMI)

Body Mass Index (BMI) at 12 months measured as kg/m2 (NCT00432809)
Timeframe: 1 year

Intervention	kg/m2 (Mean)
Medical Therapy	34.4
Gastric Bypass	26.8
Sleeve Gastrectomy	27.2

Body Weight

Body weight in kilograms (kg) measured at 12 months (NCT00432809)
Timeframe: 1 year

Intervention	kg (Mean)
Medical Therapy	99.0
Gastric Bypass	77.3
Sleeve Gastrectomy	75.5

Cardiovascular Medications - Angiotensin-converting Enzyme (ACE Inhibitor) or Angiotensin-receptor Blocker (ARB)

Number of participants taking Angiotensin-converting enzyme (ACE Inhibitor) or Angiotensin-receptor blocker (ARB) at 12 months (NCT00432809)
Timeframe: 1 year

Intervention	participants (Number)
Medical Therapy	26
Gastric Bypass	9
Sleeve Gastrectomy	11

Cardiovascular Medications - Anticoagulants

Number of participants taking anticoagulants at 12 months (NCT00432809)
Timeframe: 1 year

Intervention	participants (Number)
Medical Therapy	24
Gastric Bypass	1
Sleeve Gastrectomy	8

Cardiovascular Medications - Beta Blocker

Number of participants taking Beta Blockers at 12 months (NCT00432809)
Timeframe: 1 year

Intervention	participants (Number)
Medical Therapy	5
Gastric Bypass	9
Sleeve Gastrectomy	3

Cardiovascular Medications - Lipid Lowering Agents

Number of participants taking Lipid lowering agents at 12 months (NCT00432809)
Timeframe: 1 year

Intervention	participants (Number)
Medical Therapy	36
Gastric Bypass	13
Sleeve Gastrectomy	19

Change in Body Mass Index (BMI)

Change in Body Mass Index (BMI) at 12 months, measured in kg/m2 (NCT00432809)
Timeframe: 1 year

Intervention	kg/m2 (Mean)
Medical Therapy	-1.9
Gastric Bypass	-10.2
Sleeve Gastrectomy	-9.0

Change in Body Weight From Baseline

Mean change in body weight from baseline measured in kilograms (kg) (NCT00432809)
Timeframe: 1 year

Intervention	kg (Mean)
Medical Therapy	-5.4
Gastric Bypass	-29.4
Sleeve Gastrectomy	-25.1

Change in Glycated Hemoglobin (HbA1c)

Change in glycated hemoglobin(HbA1c)from baseline in percentage points / percent change (NCT00432809)
Timeframe: 1 year - baseline

Intervention	percentage points of glycated hemoglobin (Mean)
Medical Therapy	-1.4
Gastric Bypass	-2.9
Sleeve Gastrectomy	-2.9

Change in High-density Lipoprotein (HDL)

Percent change in high-density lipoprotein (HDL) at 12 months (NCT00432809)
Timeframe: 1 year

Intervention	mg/dL (Mean)
Medical Therapy	11.3
Gastric Bypass	28.5
Sleeve Gastrectomy	28.4

Change in High-sensitivity C-reactive Protein (Hs-CRP)

Median percent change in high-sensitivity C-reactive protein (hs-CRP)from baseline at 12 months (NCT00432809)
Timeframe: 1 year

Intervention	mg/L (Median)
Medical Therapy	-33.2
Gastric Bypass	-84
Sleeve Gastrectomy	-80

Change in Systolic Blood Pressure (SBP)

Change in Systolic Blood Pressure (SBP) at 12 months (NCT00432809)
Timeframe: 1 year

Intervention	mm Hg (Mean)
Medical Therapy	-3.9
Gastric Bypass	-2.4
Sleeve Gastrectomy	-5.1

Change in Triglycerides

Median percent change in triglycerides at 12 months from baseline measure (NCT00432809)
Timeframe: 1 year

Intervention	mg/dL (Median)
Medical Therapy	-14
Gastric Bypass	-44
Sleeve Gastrectomy	-42

Diabetes Medication - Use of Biguanides

Number of participants taking Biguanides at 12 months (NCT00432809)
Timeframe: 1 year

Intervention	participants (Number)
Medical Therapy	38
Gastric Bypass	10
Sleeve Gastrectomy	19

Diabetes Medication - Use of Incretin Mimetics

Number of participants taking Incretin Mimetics (NCT00432809)
Timeframe: 1 year

Intervention	participants (Number)
Medical Therapy	34
Gastric Bypass	1
Sleeve Gastrectomy	10

Diabetes Medication - Use of Insulin

Number of participants taking insulin at 12 months (NCT00432809)
Timeframe: 1 year

Intervention	participants (Number)
Medical Therapy	15
Gastric Bypass	2
Sleeve Gastrectomy	4

Diabetes Medication - Use of Secretagogue

Number of participants taking Secretagogues at 12 months (NCT00432809)
Timeframe: 1 year

Intervention	participants (Number)
Medical Therapy	10
Gastric Bypass	1
Sleeve Gastrectomy	5

Diabetes Medication - Use of Thiazolidinedione

Number of participants using thiazolidinedione at 12 months (NCT00432809)
Timeframe: 1 year

Intervention	participants (Number)
Medical Therapy	20
Gastric Bypass	0
Sleeve Gastrectomy	5

Fasting Plasma Glucose

Fasting Plasma Glucose measured in mg/dL. (NCT00432809)
Timeframe: 1 year

Intervention	mg/dL (Median)
Medical Therapy	120
Gastric Bypass	99
Sleeve Gastrectomy	97

Glycated Hemoglobin (HbA1c)

Mean glycated hemoglobin (HbA1c) at 12 months for each of the 3 groups, in percentage points (NCT00432809)
Timeframe: 1 year

Intervention	percentage points of glycated hemoglobin (Mean)
Medical Therapy	7.5
Gastric Bypass	6.4
Sleeve Gastrectomy	6.6

Success Rate of Biochemical Resolution of Diabetes at 12 Months as Measured by HbA1c ≤ 6% With no Diabetes Medications

The proportion of subjects with a glycated hemoglobin level of 6% or less(without diabetes medications) 12 months after randomization. (NCT00432809)
Timeframe: 1 year

Intervention	participants (Number)
Medical Therapy	0
Gastric Bypass	21
Sleeve Gastrectomy	13

Success Rate of Biochemical Resolution of Diabetes at 12 Months as Measured by HbA1c ≤ 6%.

The proportion of subjects with a glycated hemoglobin level of 6% or less(with or without diabetes medications) 12 months after randomization (baseline measure). (NCT00432809)
Timeframe: 1 year

Intervention	participants (Number)
Medical Therapy	5
Gastric Bypass	21
Sleeve Gastrectomy	18

Concentration of Metformin in Adipose Tissue

To determine the concentration of metformin in adipose tissue. (NCT03477162)
Timeframe: Within 7 days from surgery

Intervention	ng/g (Median)
Metformin	70

Concentration of Metformin in Plasma.

To determine the concentration of metformin in plasma. (NCT03477162)
Timeframe: Within 7 days from surgery

Intervention	ng/mL (Median)
Metformin	450

Concentration of Metformin in Tumor-adjacent Normal Tissue

To determine the concentration of metformin in tumor-adjacent normal tissue. (NCT03477162)
Timeframe: Within 7 days from surgery

Intervention	ng/g (Median)
Metformin	749

Concentration of Metformin in Whole Blood.

To determine the concentration of metformin in whole blood. (NCT03477162)
Timeframe: Within 7 days from surgery

Intervention	ng/mL (Median)
Metformin	514

Lung Tumor Tissue Concentration of Metformin

To determine the intra-tumor concentrations of metformin, with a standard deviation ≤25% of the mean, in patients with solid tumors of thoracic origin administered metformin extended release. (NCT03477162)
Timeframe: Within 7 days from surgery

Intervention	ng/g (Median)
Metformin	1290

Change in Arterial Stiffness Compared to Baseline

(NCT00105066)
Timeframe: Baseline and 4.5 months

Intervention	meters / second (Mean)
Placebo	-7.2
Metformin	-7.3

Change in Flow Mediated Dilation (FMD)

to evaluate improvement in endothelial function (NCT00105066)
Timeframe: Baseline and 4.5 months

Intervention	percentage change in diameter (Mean)
Placebo	8.8
Metformin	10.5

Homa Insulin Sensitivity

Homeostatic Model Assessment of insulin sensitivity (NCT00105066)
Timeframe: 4.5 months

Intervention	HOMA Score (Mean)
Placebo	57.4
Metformin	64.5

Serum Levels of ADMA at Different Time Points

ADMA- asymmetric dimethylarginine-serum concentration (NCT03398356)
Timeframe: before study start; 6 weeks from treatment start; 12 weeks from treatment start; 15 weeks from treatment start

Intervention	µM (Mean)
	6 weeks from the start of treatment	12 weeks from the start of treatment	15 weeks from the start of treatment
Group A	0.51	0.52	0.50
Group B	0.57	0.55	0.52

Serum Levels of Arginine at Different Time Points

arginine serum concentration (NCT03398356)
Timeframe: Baseline; 6 weeks from treatment start; 12 weeks from treatment start; 15 weeks from treatment start

Intervention	µM (Mean)
	6 weeks from the start of treatment	12 weeks from the start of treatment	15 weeks from the start of treatment
Group A	112.18	107.72	104.72
Group B	111.72	97.69	103.76

Serum Levels of Citrulline at Different Time Points

serum concentration of the citrulline (NCT03398356)
Timeframe: Baseline; 6 weeks from treatment start; 12 weeks from treatment start; 15 weeks from treatment start

Intervention	µM (Mean)
	6 weeks from the start of treatment	12 weeks from the start of treatment	15 weeks from the start of treatment
Group A	21.73	25.95	26.93
Group B	28.08	27.01	29.77

Serum Levels of DMA at Different Time Points

DMA- dimethylamine, serum concentration (NCT03398356)
Timeframe: Baseline; 6 weeks from treatment start; 12 weeks from treatment start; 15 weeks from treatment start

Intervention	µM (Mean)
	6 weeks from the start of treatment	12 weeks from the start of treatment	15 weeks from the start of treatment
Group A	1.71	1.63	1.62
Group B	2.07	1.89	1.84

Serum Levels of Metformin at Different Time Points

the serum concentration of the studied drug-metformin (NCT03398356)
Timeframe: 6 weeks from treatment start; 12 weeks from treatment start; 15 weeks from treatment start

Intervention	µM (Mean)
	6 weeks from the start of treatment	12 weeks from the start of treatment	15 weeks from the start of treatment
Group A	4.36	5.09	4.66
Group B	4.25	7.42	4.01

Serum Levels of SDMA at Different Time Points

SDMA-symmetric dimethylarginine-serum concentration (NCT03398356)
Timeframe: Baseline; 6 weeks from treatment start; 12 weeks from treatment start; 15 weeks from treatment start

Intervention	µM (Mean)
	6 weeks from the start of treatment	12 weeks from the start of treatment	15 weeks from the start of treatment
Group A	0.40	0.41	0.39
Group B	0.45	0.42	0.39

Percent Change in Triglyceride (TG) Levels Post Treatment

The reported percent change is the difference between TG levels obtained on initial visit (day 0) and TG levels obtained at final visit (week 12) as per protocol (NCT00819910)
Timeframe: 12 weeks from initial visit (day 0) to final visit (12 weeks)

Intervention	% change (Mean)
Rosiglitazone + Placebo	7.4
Fenofibrate + Placebo	-2.2
Rosiglitazone +Fenofibrate	20
Placebo Therapy Daily	7.6

Post-treatment Percent Change in High-Density Lipoprotein (HDL) Levels

The reported percent change is the difference between HDL levels obtained on initial visit (day 0) and HDL levels obtained at final visit (week 12) as per protocol (NCT00819910)
Timeframe: 12 weeks from initial visit (day 0) to final visit (12 weeks)

Intervention	% change (Mean)
Rosiglitazone and Placebo	1.9
Fenofibrate + Placebo	14.5
Rosiglitazone +Fenofibrate	5.8
Placebo Therapy Daily	1.7

Post-treatment Percent Change in Low-Density Lipoprotein (LDL) Levels

The reported percent change is the difference between LDL levels obtained on initial visit (day 0) and LDL levels obtained at final visit (week 12) as per protocol (NCT00819910)
Timeframe: 12 weeks from initial visit (day 0) to final visit (12 weeks)

Intervention	% change (Mean)
Rosiglitazone + Placebo	-0.5
Fenofibrate + Placebo	2.6
Rosiglitazone + Fenofibrate	37.3
Placebo Therapy Daily	13.7

Mean Levels of Aspartate Aminotransferase (AST) and Alanine Aminotransferase (ALT) at Initial Visit and Final Visit

The mean Levels of AST and ALT measured at initial visit (Day 0) and final visit (Week 12) annotated as AST 1, AST 12, and ALT 1 and ALT 12, respectively. (NCT00819910)
Timeframe: 12 weeks from initial visit (day 0) to final visit (12 weeks)

,,,

Intervention	mg/dl (Mean)
	AST 1 (aspartate aminotransferase [10-35 U/L])	AST 12 (aspartate aminotransferase [15-37 U/L])	ALT 1 (alanine aminotransferase [6-60 U/L])	ALT 12 (alanine aminotransferase [6-60 U/L])
Fenofibrate + Placebo	25.25	26.50	25.88	26.38
Placebo Therapy Daily	19.88	17.88	20.88	14.88
Rosiglitazone + Placebo	24.00	30.29	28.14	27.43
Rosiglitazone +Fenofibrate	24.30	19.70	24.10	21.10

Post-treatment Percent Change in Apolipoprotein A-I (Apo AI), Apolipoprotein A-II (Apo AII) and Apolipoprotein C-III (Apo CIII) Levels

Post-treatment median change in Apo AI, Apo AII and Apo CIII levels reported in mg/dL with Interquartile ranges provided (NCT00819910)
Timeframe: 12 weeks from initial visit (day 0) to final visit (12 weeks)

,,,

Intervention	% Change (Median)
	Apo AI	Apo AII	Apo CIII
Fenofibrate + Placebo	13	3.4	-4.35
Placebo Therapy Daily	5	-3.5	-2.3
Rosiglitazone + Placebo	-1.00	10.25	0.30
Rosiglitazone +Fenofibrate	1	7.2	-5.3

Reviews

6 reviews available for glyburide and Diabetic Angiopathies

Article	Year
Treatment of patients over 64 years of age with type 2 diabetes: experience from nateglinide pooled database retrospective analysis. Diabetes care, 2003, Volume: 26, Issue:7 Topics: Aged; Blood Glucose; Body Mass Index; Comorbidity; Cyclohexanes; Diabetes Mellitus, Type 2; Diabetic	2003
[Antidiabetic therapy in diabetic patients with coronary heart disease]. Minerva medica, 2003, Volume: 94, Issue:6 Topics: Administration, Oral; Coronary Disease; Delayed-Action Preparations; Diabetes Complications; Diabete	2003
A systematic review and meta-analysis of hypoglycemia and cardiovascular events: a comparison of glyburide with other secretagogues and with insulin. Diabetes care, 2007, Volume: 30, Issue:2 Topics: Cardiovascular Diseases; Diabetic Angiopathies; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents	2007
Sulfonylureas and platelet function. The American journal of medicine, 1981, Volume: 70, Issue:3 Topics: Adenosine Diphosphate; Blood Glucose; Blood Platelets; Collagen; Diabetes Mellitus; Diabetic Angiopa	1981
[Experience and present status: glibenclamide (Daonil), a reference molecule]. Journees annuelles de diabetologie de l'Hotel-Dieu, 1994 Topics: Blood Glucose; Diabetic Angiopathies; Glyburide; Humans; Hyperinsulinism; Reference Standards	1994
[What is achieved by the therapy with oral antidiabetics?]. Der Internist, 1976, Volume: 17, Issue:12 Topics: Administration, Oral; Adult; Biguanides; Chlorpropamide; Diabetes Mellitus; Diabetic Angiopathies; D	1976

Trials

10 trials available for glyburide and Diabetic Angiopathies

Article	Year
Improvement of cardio-ankle vascular index by glimepiride in type 2 diabetic patients. International journal of clinical practice, 2010, Volume: 64, Issue:13 Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Ankle; Deoxyguanosine; Diabetes Mellitus, Type 2; Diabetic Angiop	2010
Nateglinide provides tighter glycaemic control than glyburide in patients with Type 2 diabetes with prevalent postprandial hyperglycaemia. Diabetic medicine : a journal of the British Diabetic Association, 2011, Volume: 28, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Cyclohexanes; Diabetes Mellitus, Type 2; Di	2011
Preoperative shift from glibenclamide to insulin is cardioprotective in diabetic patients undergoing coronary artery bypass surgery. The Journal of cardiovascular surgery, 2004, Volume: 45, Issue:2 Topics: Aged; Anesthetics, Inhalation; Angina Pectoris; Cardiotonic Agents; Coronary Disease; Creatine Kinas	2004
Repaglinide administration improves brachial reactivity in type 2 diabetic patients. Diabetes care, 2005, Volume: 28, Issue:2 Topics: Aged; Blood Glucose; Brachial Artery; Carbamates; Cross-Over Studies; Diabetes Mellitus, Type 2; Dia	2005
The potential of gliclazide, a sulphonylurea to influence the oxidative processes within the pathogenesis of diabetic vascular disease. Advances in experimental medicine and biology, 1994, Volume: 366 Topics: Adult; Aged; Analysis of Variance; Animals; Blood Glucose; Diabetic Angiopathies; Free Radical Scave	1994
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi	1998
Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes. Diabetes care, 2002, Volume: 25, Issue:3 Topics: Blood Glucose; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Chromans; D	2002
Platelet behaviour in non-insulin-dependent diabetes--influence of vascular complications, treatment and metabolic control. Thrombosis and haemostasis, 1986, Jun-30, Volume: 55, Issue:3 Topics: Adenosine Diphosphate; Blood Platelets; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Epinephrin	1986
Lack of effect of gliclazide on platelet aggregation in insulin-treated and non-insulin-treated diabetes: a two-year controlled study. Diabetes research and clinical practice, 1988, Jan-07, Volume: 4, Issue:2 Topics: Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathie	1988

Other Studies

28 other studies available for glyburide and Diabetic Angiopathies

Article	Year
Comparative Safety of Sulfonylureas and the Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia. Diabetes care, 2018, Volume: 41, Issue:4 Topics: Aged; Arrhythmias, Cardiac; Cause of Death; Death, Sudden, Cardiac; Diabetic Angiopathies; Female; G	2018
Comparison of mortality and cardiovascular event risk associated with various insulin secretagogues: A nationwide real-world analysis. Diabetes research and clinical practice, 2019, Volume: 152 Topics: Aged; Carbamates; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angio	2019
Risk of acute coronary events associated with glyburide compared with gliclazide use in patients with type 2 diabetes: a nested case-control study. Diabetes, obesity & metabolism, 2014, Volume: 16, Issue:1 Topics: Acute Coronary Syndrome; Aged; Alberta; Case-Control Studies; Cohort Studies; Diabetes Mellitus, Typ	2014
Comparative cardiovascular safety of insulin secretagogues following hospitalization for ischemic heart disease among type 2 diabetes patients: a cohort study. Journal of diabetes and its complications, 2015, Volume: 29, Issue:2 Topics: Aged; Aged, 80 and over; Alberta; Blue Cross Blue Shield Insurance Plans; Carbamates; Cardiovascular	2015
Combination Therapy of Nifedipine and Sulphonylureas Exhibits a Mutual Antagonistic Effect on the Endothelial Cell Dysfunction Induced by Hyperglycemia Linked to Vascular Disease. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2016, Volume: 38, Issue:6 Topics: Antihypertensive Agents; Biphenyl Compounds; Cell Movement; Diabetic Angiopathies; Drug Synergism; E	2016
Glimepiride upregulates eNOS activity and inhibits cytokine-induced NF-kappaB activation through a phosphoinoside 3-kinase-Akt-dependent pathway. Diabetes, obesity & metabolism, 2009, Volume: 11, Issue:2 Topics: Blotting, Western; Cells, Cultured; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelial Ce	2009
Risk of coronary artery disease associated with initial sulphonylurea treatment of patients with type 2 diabetes: a matched case-control study. Diabetes research and clinical practice, 2008, Volume: 82, Issue:3 Topics: Adult; Case-Control Studies; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathi	2008
Adverse cardiovascular events during treatment with glyburide (glibenclamide) or gliclazide in a high-risk population. Diabetic medicine : a journal of the British Diabetic Association, 2012, Volume: 29, Issue:12 Topics: Aged; Angioplasty, Balloon, Coronary; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathi	2012
Influence of diabetic state and that of different sulfonylureas on the size of myocardial infarction with and without ischemic preconditioning in rabbits. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2002, Volume: 110, Issue:5 Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Glyburide; Hypoglycemic Agents; Isc	2002
Impaired hypoxic coronary vasodilation and ATP-sensitive potassium channel function: a manifestation of diabetic microangiopathy in humans? Circulation research, 2003, Feb-07, Volume: 92, Issue:2 Topics: Adenosine Triphosphate; Coronary Vessels; Diabetic Angiopathies; Glyburide; Humans; Hypoxia; Microci	2003
Optimal glycemic control in type 2 diabetes mellitus: fasting and postprandial glucose in context. Archives of internal medicine, 2004, Mar-08, Volume: 164, Issue:5 Topics: Antihypertensive Agents; Blood Glucose; Blood Glucose Self-Monitoring; Carbamates; Diabetes Mellitus	2004
Improvement in coronary vascular dysfunction produced with euglycaemic control in patients with type 2 diabetes. Heart (British Cardiac Society), 2007, Volume: 93, Issue:3 Topics: Blood Glucose; Blood Pressure; Case-Control Studies; Coronary Circulation; Coronary Disease; Diabete	2007
Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted? Diabetes care, 2008, Volume: 31 Suppl 2 Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Glyburide; Humans; Hypogl	2008
Sulfonylureas and platelet function. The American journal of medicine, 1983, Volume: 74, Issue:5 Topics: Diabetic Angiopathies; Glyburide; Humans; Platelet Aggregation	1983
[Experience with diamicron treatment of diabetics]. Klinicheskaia meditsina, 1984, Volume: 62, Issue:11 Topics: Adult; Aged; Chronic Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Evaluation; Dru	1984
The effects of gliclazide and other sulfonylureas on low-density lipoprotein oxidation in vitro. Metabolism: clinical and experimental, 1997, Volume: 46, Issue:12 Suppl 1 Topics: Administration, Oral; Adult; Antioxidants; Ascorbic Acid; Coronary Artery Disease; Diabetes Mellitus	1997
Chorea in hyperglycemia. Diabetes care, 1998, Volume: 21, Issue:10 Topics: Aged; Aged, 80 and over; Brain; Chorea; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Gl	1998
Myocardial infarction in diabetic vs non-diabetic subjects. Survival and infarct size following therapy with sulfonylureas (glibenclamide) European heart journal, 2000, Volume: 21, Issue:3 Topics: Aged; Case-Control Studies; Creatine Kinase; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Femal	2000
Cardiomyopathic changes in streptozotocin-induced diabetes. Proceedings of the Western Pharmacology Society, 1999, Volume: 42 Topics: Adenosine Triphosphatases; Animals; Body Weight; Calcium Channel Blockers; Cardiomyopathies; Cardiot	1999
Diabetes, coronary heart disease and sulphonylureas-not the final word. European heart journal, 2000, Volume: 21, Issue:10 Topics: Diabetic Angiopathies; Glyburide; Humans; Hypoglycemic Agents; Myocardial Infarction; Potassium Chan	2000
Lipid peroxidation and antioxidant enzyme status in Type 2 diabetics with coronary heart disease. Diabetes research and clinical practice, 2001, Volume: 53, Issue:1 Topics: Catalase; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Coronary Disease; Diab	2001
Treatment of type 2 diabetes: the sooner, the better. Journal of internal medicine, 2001, Volume: 250, Issue:3 Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Follow-Up Studies; Glyburide; Glycat	2001
Influence of ATP-sensitive K+ channel modulation on the mechanical properties of diabetic myocardium. Endocrine research, 2001, Volume: 27, Issue:3 Topics: Adenosine Triphosphate; Animals; Biomechanical Phenomena; Blood Glucose; Cromakalim; Depression, Che	2001
Post-stenotic coronary blood flow at rest is not altered by therapeutic doses of the oral antidiabetic drug glibenclamide in patients with coronary artery disease. Heart (British Cardiac Society), 2002, Volume: 87, Issue:1 Topics: Administration, Oral; Blood Glucose; Coronary Angiography; Coronary Circulation; Coronary Stenosis;	2002
Diabetic microangiopathy in KK mice. V. Effect of early glyburide treatment of kidney glucosyltransferase activity. Experimental and molecular pathology, 1978, Volume: 29, Issue:3 Topics: Animals; Blood Glucose; Diabetic Angiopathies; Diabetic Nephropathies; Glucosyltransferases; Glyburi	1978
[Diabetes mellitus and its complications in Japan. The determination of glycemic threshold for the regression or prevention of diabetic microangiopathies, and insulin injection regimen to establish strict glycemic control in NIDDM]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1991, Sep-10, Volume: 80, Issue:9 Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Administration Schedule;	1991
The effect of sulfonylurea therapy on defective calcium movement associated with diabetic cardiomyopathy. Canadian journal of physiology and pharmacology, 1989, Volume: 67, Issue:11 Topics: Adenosine Triphosphate; Animals; Blood Glucose; Ca(2+) Mg(2+)-ATPase; Calcium; Calcium-Transporting	1989
Insulinotropic action of a new sulfonylurea: gliclazide. Revue europeenne d'etudes cliniques et biologiques. European journal of clinical and biological research, 1972, Volume: 17, Issue:3 Topics: Animals; Cyclopentanes; Diabetic Angiopathies; Dogs; Drug Interactions; Fatty Acids, Nonesterified;	1972